As of the latest Form 4 filed Jul 2, 2026.
What Orchestra BioMed Holdings Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 23 most recent filings for OBIO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-07-01 | Sherman Darren See Remarks | SSale | −15.0K | $4.27 | $64.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-25 | 2026-06-24 | Fain Eric S Director | FTax | −4.26K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-24 | Pacitti David Director | FTax | −3.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-24 | Cleary Chris Director | FTax | −3.51K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-24 | Mack John Prosper Director | FTax | −3.51K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Fain Eric S Director | AAward | +17.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Pacitti David Director | AAward | +17.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Connealy Pamela Ann Director | AAward | +17.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-25 | 2026-06-23 | Mack John Prosper Director | AAward | +34.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-10 | Taylor Andrew Lawrence Chief Financial Officer | FTax | −36.4K | $4.02 | $146K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-10 | Hochman David P See Remarks | FTax | −3.28K | $4.02 | $13.2K | No | Form 4 ↗ |
| 2026-06-12 | 2026-06-10 | Hochman David P, See Remarks | FTax | −3.28K | $4.02 | $13.2K | No | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Hochman David P See Remarks | PPurchase | +5.00K | $3.83 | $19.1K | No | Form 4 ↗ |
| 2026-06-02 | 2026-06-01 | Sherman Darren See Remarks | SSale | −15.0K | $3.87 | $58.0K | Yes (planned) | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Taylor Andrew Lawrence Chief Financial Officer | FTax | −3.08K | $3.98 | $12.2K | No | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Sherman Darren See Remarks | FTax | −4.92K | $3.98 | $19.6K | No | Form 4 ↗ |
| 2026-05-20 | 2026-05-18 | Aryeh Jason Director | PPurchase | +665.00 | $3.75 | $2.49K | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | RTW INVESTMENTS, LP 10% owner | SSale | −32.00 | $4.13 | $132.16 | No | Form 4 ↗ |
| 2026-04-29 | 2026-04-27 | RTW INVESTMENTS, LP, 10% owner | XX | +1.25M | $0.00 | $125.00 | No | Form 4 ↗ |
| 2026-03-27 | 2026-03-25 | Sherman Darren See Remarks | FTax | −33.3K | $4.57 | $152K | No | Form 4 ↗ |
| 2026-03-27 | 2026-03-25 | Aiello Joshua Principal Accounting Officer | FTax | −241.00 | $4.57 | $1.10K | No | Form 4 ↗ |
| 2026-03-27 | 2026-03-25 | Hochman David P See Remarks | FTax | −32.4K | $4.57 | $148K | No | Form 4 ↗ |
| 2026-03-16 | 2026-03-13 | Hochman David P See Remarks | PPurchase | +10.0K | $4.29 | $42.9K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also OBIO’s full analysis or the market-wide insider trading feed. The tabs above jump to OBIO’s other SEC data.
Source: SEC Form 4 filings for OBIO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.